Join
Live feed
·
PRReleasevia Quantisnow
Aridis Pharmaceuticals Inc. logo

Aridis Pharmaceuticals to Discuss Topline Data from Phase 3 Study of AR-301 During Corporate Update Call on January 25

ByQuantisnow·Wall Street's wire, on your screen.
ARDS· Aridis Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARDS (Aridis Pharmaceuticals Inc.) and more on Quantisnow.